KP Tissue and Kruger Products Report First Quarter 2013 Results
May 14, 2013 - KP Tissue Inc. ("KPT"), which holds a limited partnership interest in Kruger Products L.P. ("KPLP"), releases the financial results for KPT and KPLP for the first quarter of 2013. KPLP is Canada's leading manufacturer of quality tissue products for household and commercial use.
KP Tissue Inc. and Kruger Products L.P.
KPT was created to acquire, and its business is limited to holding, a limited partnership interest in KPLP. As of March 31, 2013, KPT held a 16.9% interest in KPLP, accounted for as an investment on the equity basis. The financial results presented for KPT represent its holding in KPLP during the first quarter of 2013. The following discussion and analysis, unless identified specifically as representing the financial results of only KPT, relates entirely to the financial results of KPLP. Accordingly, the results of KPLP apply to KPT only to the extent of its holding in KPLP.
On April 15, 2013, KPLP paid a distribution to its partners. Following the reinvestment by the partners of KPLP of a portion of such distribution pursuant to KPLP's distribution reinvestment plan, KPT held a 16.9% interest in KPLP.
Q1 2013 Highlights
- Revenue of $221.8 million in Q1 2013, compared to $216.2 million in Q1 2012, an increase of 2.6 percent year over year
- EBITDA of $25.1 million in Q1 2013 (including $1.8 million of TAD Project start-up costs) compared to $27.2 million in Q1 2012 (including $0.8 million of TAD Project start-up costs), a decrease of 7.8 percent year over year
- Net income of $11.7 million in Q1 2013 compared to $0.4 million in Q1 2012, an increase of $11.3 million year over year
- Cash balance of $92.4 million as of March 31, 2013 compared to $121.5 million as of December 31, 2012
"The first quarter of 2013 was highlighted by the completion of the construction phase of our TAD Project, and we began our first customer deliveries. We are carrying out our strategy to gradually ramp up TAD product sales in 2013, which should generate a modest positive contribution to EBITDA for the year as a whole, " said Mario Gosselin, CEO of KP Tissue and KPLP.
"Revenue for the first quarter 2013 was $221.8 million, up 2.6% over 2012. We benefited from additional days of sales in the quarter and solid growth in the U.S. business. This was partially offset by our decision last year to cease production of parent rolls for sale. While our private label revenue was strong, sales in our Canadian branded business were somewhat soft in Q1 primarily due to the timing of our promotional activities. We expect revenue to improve in Q2 over Q1.
"First quarter EBITDA of $25.1 million decreased compared to the same period in 2012, but increased compared to the EBITDA we achieved in the fourth quarter of 2012. Q1 EBITDA benefited year-over-year from the business rationalization program we implemented last year along with reduced management fees. These gains were impacted by start-up costs for the TAD Project and higher fibre and energy costs. In addition, our Away-From-Home Segment EBITDA returned to a more normalized level in the first quarter.
"We look ahead to the rest of 2013 with confidence in our business model considering the positioning of our brands and the strong initial reaction of customers to our TAD products in the premium private label market," Mr. Gosselin concluded.
KPLP Q1 2013 Financial Results
Revenue in Q1 2013 was $221.8 million, an increase of 2.6 percent compared to Q1 2012. Compared to Q1 2012, revenue was positively impacted by volume and mix increases primarily related to an additional 5 days of sales in Q1 2013 compared to Q1 2012. The increases in revenue compared to Q1 2012 were driven by increases in Consumer and AFH segment revenues, partially offset by declines in Other segment revenue primarily as a result of the decision to cease production of parent rolls for sale at the New Westminster plant in Q1 2012.
Cost of sales in Q1 2013 was $157.2 million, compared to $151.6 million in Q1 2012. As a percentage of revenue, cost of sales increased to 70.9 percent in Q1 2013 from 70.1 percent in Q1 2012 primarily due to increases in commodity prices, particularly pulp fibre.
Operating expenses in Q1 2013 were $47.9 million, compared to $43.0 million in Q1 2012. Compared to Q1 2012, operating expenses increased primarily due to higher sales, logistics and marketing related expenses, public company costs paid on behalf of KPT and the unfavourable impact of foreign exchange.
EBITDA in Q1 2013 was $25.1 million, compared to $27.2 million in Q1 2012. EBITDA in Q1 2013 included $1.8 million of TAD Project start-up costs compared to $0.8 million in Q1 2012. Compared to Q1 2012, EBITDA decreased primarily due to increased fibre costs and operating expenses, partially offset by higher sales volumes.
Net income in Q1 2013 was $11.7 million, compared to $0.4 million in Q1 2012. Compared to Q1 2012, net income increased primarily due to a deferred tax credit related to the U.S. operations in Q1 2013, partially offset by an increase in interest expense related to the TAD Project and lower EBITDA.
The cash balance as of March 31, 2013 was $92.4 million, down from $121.5 million as of December 31, 2012. The decrease in cash was primarily driven by cash used in operations related to a higher inventory balance at the end of Q1 2013 required to meet expected Q2 2013 demand and a decline in accounts payable due to timing. The cash balance was also impacted by capital expenditures of $22.7 million, of which $19.7 million related to the TAD Project and $3.0 million related to existing sites. This compared to capital expenditures in Q1 2012 of $33.4 million, of which $28.8 million related to the TAD
Project and $4.6 million related to existing sites. The decreases in the cash balance were partially offset by proceeds of $12.3 million from the issuance of partnership units related to the partial exercise of the overallotment option in Q1 2013.
- Net loss of $0.7 million in Q1 2013
- Loss per share of $0.08 in Q1 2013
- Declared quarterly dividend of $0.18 per share, payable July 15, 2013
KPT Q1 2013 Financial Results
Included in the net loss of $0.7 million in Q1 2013 was $2.0 million representing KPT's share of KPLP's profit. The profit was more than offset by depreciation of $2.7 million related to adjustments to carrying amounts on acquisition, and income tax expense of $0.3 million.
About KP Tissue Inc.
KPT was created to acquire, and its business is limited to holding, a limited partnership interest in KPLP. For more information visit www.kptissueinc.com.
About Kruger Products L.P.
KPLP is Canada's leading manufacturer of quality tissue products for household, industrial and commercial use. KPLP serves the Canadian consumer market with such well-known brands as Cashmere®, Purex®, SpongeTowels®, Scotties®' and White Swan®. In the U.S., KPLP manufactures the White Cloud® brand, as well as many private label products. The Away-From-Home division manufactures and distributes high-quality, cost-effective product solutions to a wide range of commercial and public entities. KPLP has approximately 2,300 employees across North America and operates five FSC® CoC- certified mills (FSC® C104904), four of which are located in Canada and one in the US. For more information visit www.krugerproducts.ca.
SOURCE: KP Tissue Inc